1. J Allergy Clin Immunol. 2021 Feb;147(2):746-749.e9. doi: 
10.1016/j.jaci.2020.07.024. Epub 2020 Aug 5.

Lupus-like autoimmunity and increased interferon response in patients with 
STAT3-deficient hyper-IgE syndrome.

Goel RR(1), Nakabo S(1), Dizon BLP(2), Urban A(3), Waldman M(4), Howard L(4), 
Darnell D(3), Buhaya M(3), Carmona-Rivera C(1), Hasni S(1), Kaplan MJ(1), 
Freeman AF(5), Gupta S(6).

Author information:
(1)Systemic Autoimmunity Branch, National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
(2)Rheumatology Training Program, National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
(3)Laboratory of Clinical Immunology and Microbiology, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
(4)Kidney Diseases Branch, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health, Bethesda, Md.
(5)Laboratory of Clinical Immunology and Microbiology, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. 
Electronic address: freemaal@mail.nih.gov.
(6)Systemic Autoimmunity Branch, National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md. 
Electronic address: sarthak.gupta@nih.gov.

We report on patients with STAT3 loss-of-function (LOF) mutations who developed 
lupus-like autoimmunity. Immune dysregulation seen in STAT3 LOF patients 
suggests a susceptibility to systemic autoimmunity with important implications 
in monitoring and management of these patients.

DOI: 10.1016/j.jaci.2020.07.024
PMCID: PMC7862417
PMID: 32768442 [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest: the authors declare no 
conflict of interest.